Financhill
Back

Spyre Therapeutics Quote, Financials, Valuation and Earnings

Sell
48

SYRE
Spyre Therapeutics

Last Price:
37.77
Seasonality Move:
7.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Spyre Therapeutics Price Quote

$37.77
-0.03 (-0.08%)
(Updated: May 18, 2024 at 5:54 AM ET)

Spyre Therapeutics Key Stats

Sell
48
Spyre Therapeutics (SYRE) is a Sell

Day range:
$36.94 - $38.18
52-week range:
$2.66 - $47.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
620.92
P/B ratio:
0%

Volume:
308.3K
Avg. volume:
311.1K
1-year change:
908%
Market cap:
$1.5B
Revenue:
$886K
EPS:
$-69.04

How Much Does Spyre Therapeutics Make?

Data Unavailable

Is Spyre Therapeutics Growing As A Company?

Data Unavailable

Spyre Therapeutics Stock Price Performance

What Is Spyre Therapeutics 52-Week High & Low?

Spyre Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Spyre Therapeutics?

Is Spyre Therapeutics Cash Flow Positive?

  • What Is SYRE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$110.8M
  • What Is Spyre Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $533.2M
  • What Is Spyre Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$231.1M

Spyre Therapeutics Return On Invested Capital

Data Unavailable

Spyre Therapeutics Earnings Date & Stock Price

Spyre Therapeutics Competitors

Spyre Therapeutics Dividend Yield

Data Unavailable

Spyre Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -11.11%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 45.00
Upside from Last Price: 19.05%

Major Shareholders

  • How many SYRE shares are owned by institutional investors?
    47.2M SYRE shares are owned by institutional investors
  • How many SYRE shares are owned by insiders?
    2.4M SYRE shares are owned by insiders